SCHEMBL7363983

SCHEMBL7363983

COc1ccc(-c2ccc(O[Si](C)(C)C(C)(C)C)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PREP P48147 4/20 0.54
ESR2 Q92731 1/20 0.47
CA12 O43570 5/20 0.44
CA1 P00915 5/20 0.44
CA9 Q16790 5/20 0.44
CA2 P00918 1/20 0.44
CA7 P43166 1/20 0.44
CA14 Q9ULX7 1/20 0.44
KDM4E B2RXH2 1/20 0.43
USP2 O75604 1/20 0.43
ENPP3 O14638 1/20 0.43
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
CLK4 Q9HAZ1 1/20 0.42
TP53 P04637 1/20 0.42
MAPK1 P28482 1/20 0.42
CASP3 P42574 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
SENP8 Q96LD8 1/20 0.42
SENP7 Q9BQF6 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3057447 0.94 CA1 (0.50) PREPCA12CA1CA9CA2
SCHEMBL23491348 0.92 PREP (0.57) PREPESR2CA12CA1CA9
SCHEMBL6763899 0.85 PREP (0.53) PREPCA12CA1CA9CA2
SCHEMBL30758292 0.85 ABL1 (0.56) PREPCA12CA1CA9KDM4E
SCHEMBL16171288 0.84 PREP (0.51) PREPCA12CA1CA9CA2
SCHEMBL2607317 0.84 PREP (0.51) PREPCA12CA1CA9KDM4E
SCHEMBL20364924 0.84 PREP (0.55) PREPCA12CA1CA9ENPP3
SCHEMBL17782436 0.83 MAPT (0.61) PREPKDM4ENPC1RAB9AMAPK1
SCHEMBL7366758 0.82 PREP (0.50) PREPCA12CA1CA9NPC1
SCHEMBL5379895 0.82 PREP (0.53) PREPESR2CA12CA1CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5296479-A Treating physiological or drug-induced psychosis or dyskinesia THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1994-03-22 US disclosed
US-5266572-A Antipsychotic 1-cycloalkylpiperidines THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1993-11-30 US disclosed
US-5243048-A Treatment of drug-induced or physiological psychosis or dyskinesia; side effect reduction THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1993-09-07 US disclosed
EP-0490962-A1 ANTIPSYCHOTIC 1-CYCLOALKYLPIPERIDINES THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1992-06-24 EP disclosed
US-5109002-A ANTIPSYCHOTIC 1-CYCLOALKYLPIPERIDINES DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1992-04-28 US disclosed
WO-1991003243-A1 ANTIPSYCHOTIC 1-CYCLOALKYLPIPERIDINES THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1991-03-21 WO disclosed